drugset / Trial / NCT01023711
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to describe the immune response to a novel H1N1 influenza vaccination in healthy adults, and to understand the factors that allow healthy adults to respond to a single dose of vaccine even if they have never previously experience novel H1N1 disease or vaccination.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-11
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inactivated H1N1 Vaccine | Vaccine | 0.5 ml | Intramuscular |